Parkinson's gene hunt: 230 patients join national biobank

NCT ID NCT05721911

Recruiting now Knowledge-focused Sponsor: IRCCS San Raffaele Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is creating a national biobank of blood samples and health data from 230 people with Parkinson's disease or a related sleep disorder (REM sleep behavior disorder). Researchers will analyze the complete DNA of each participant to find rare genetic changes that may cause or contribute to the disease. They will also create stem cell lines from blood samples to study how these genetic variants affect brain cells. The goal is to better understand the genetic roots of Parkinson's, which could lead to new treatments in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could identify new genetic variants linked to Parkinson's, paving the way for future targeted treatments or early detection methods.
What could go wrong: This is an observational biobank study, not a treatment trial. It may not directly benefit participants, and genetic findings may take years to translate into therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease REM sleep behavior disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE REM SLEEP BEHAVIOR DISORDER

Contacts and locations

Locations

IRCCS San Raffaele
RECRUITING

Milan, Italy, 20132, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.